NCT06340646NARecruiting

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

Washington University School of Medicine

Start Date

10/18/2022

Completion Date

1/31/2027

Summary

The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.

Eligibility Criteria

Age Range: 18 years to No maximum

Eligibility Criteria: * Patients with cholangiocarcinoma, multiple myeloma, or early onset colon or rectal cancer. * If diagnosed with multiple myeloma, must be African-American. * If diagnosed with colon or rectal cancer, must be African-American AND must be no older than 65 years old at the time of diagnosis. * At least 18 years old * Able to understand and willing to sign an IRB-approved written informed consent document

Interventions

OTHER

Return of Genetic Results: Biomarker information from cancer cells

OTHER

Return of Genetic Results: Inherited mutations related to cancer

OTHER

Return of Genetic Results: Inherited mutations related to other medical issues

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

CholangiocarcinomaMultiple MyelomaColon CancerRectal Cancer

Locations

Washington University School of Medicine

St Louis, Missouri 63110

United States